Adam Booth, MD, FCAP, discusses a blood-based test for colon cancer. He highlighted the test’s limitations, including its insensitivity when detecting advanced precancerous lesions, but was broadly positive about the rollout of any kind of test that “removes potential barriers [to diagnosis] for some patients.”
For the full article click here: FDA approves blood-based test for colorectal cancer as expert says it could help early detection